| No competing risk | Competing risk included | ||||
---|---|---|---|---|---|---|
 | HR | 95% CI | p-value | HR | 95% CI | p-value |
Agea | 1.581 | 1.540–1.629 | < 0.001 | 1.542 | 1.493–1.581 | < 0.001 |
Male sex (vs. female) | 3.122 | 2.786–3.496 | < 0.001 | 3.040 | 2.710–3.401 | < 0.001 |
Family history of chronic liver disease | 2.490 | 2.143–2.893 | < 0.001 | 2.487 | 2.099–2.948 | < 0.001 |
ALTa | 1.049 | 1.044–1.054 | < 0.001 | 1.048 | 1.036–1.061 | < 0.001 |
GGTa | 1.030 | 1.027–1.032 | < 0.001 | 1.029 | 1.026–1.032 | < 0.001 |
Total cholesterola | 0.897 | 0.886–0.908 | < 0.001 | 0.898 | 0.887–0.910 | < 0.001 |
Chronic liver disease | 3.430 | 3.096–3.800 | < 0.001 | 3.470 | 3.116–3.863 | < 0.001 |
Chronic hepatitis virus infection | 1.851 | 1.605–2.135 | < 0.001 | 1.862 | 1.567–2.213 | < 0.001 |
HIV infection | 4.097 | 3.691–4.546 | < 0.001 | 4.057 | 3.640–4.522 | < 0.001 |
Diabetes mellitus | 1.427 | 1.257–1.619 | < 0.001 | 1.430 | 1.255–1.629 | < 0.001 |
Dyslipidemia | 0.479 | 0.382–0.601 | < 0.001 | 0.458 | 0.359–0.585 | < 0.001 |
Schizophrenic or delusional disorders, or mental disorders due to psychoactive substance use | 0.655 | 0.575–0.747 | < 0.001 | 0.645 | 0.563–0.738 | < 0.001 |
Overweight (vs. normal) | 1.182 | 1.080–1.294 | < 0.001 | 1.190 | 1.084–1.308 | < 0.001 |
Obese (vs. normal) | 1.648 | 1.297–2.094 | < 0.001 | 1.662 | 1.304–2.118 | < 0.001 |
Middle income (vs. low) | 0.926 | 0.836–1.025 | 0.138 | 0.925 | 0.831–1.030 | 0.150 |
High income (vs. low) | 0.832 | 0.749–0.925 | < 0.001 | 0.834 | 0.747–0.931 | 0.001 |